| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078277 For therapy and prophylaxis of depression; Tourette syndrome, autism, bipolar disorder, cyclothymia, schizophrenia, Alzheimer disease, obesity, diabetes, alcohol dependence, sleep disorder, insomnia, migraine, stress headache, etc. |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078267 Oxidation of a dihydro-pyrazolopyridazine |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030075216 Synthesis of perylene-porphyrin building blocks and polymers thereof for the production of light-harvesting arrays |
| 04/24/2003 | CA2722197A1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 04/24/2003 | CA2463571A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/23/2003 | EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 04/23/2003 | EP1303518A1 Imidazolophthalazine derivatives as ligands for gabaa receptors |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303516A1 Imidazolophthalazine derivatives as ligands for gaba a? receptors |
| 04/23/2003 | EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles |
| 04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 04/23/2003 | EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 04/23/2003 | EP1237892B1 Method for producing epinastine hydrochloride in the high-melting crystal modification |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/23/2003 | EP1144512B1 Novel colorants, colorant stabilizers, ink compositions, and improved methods of making the same |
| 04/23/2003 | EP1045851B1 Substituted porphyrins |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP1028962B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides |
| 04/23/2003 | CN1413215A Process for preparation of pyrazolo pyridazine derivatives |
| 04/23/2003 | CN1413214A Peptide beta turn mimetic compounds and process for making them |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413112A Nasal drops containing fused pyridazine derivatives |
| 04/23/2003 | CN1412190A Synthesis process of matrine tannate |
| 04/23/2003 | CN1412189A Method for synthesizing 3 (or8)-(1-methoxyethyl)-8-(or3)-(1-hydroxyethyl)-deuteroporphyrin IX |
| 04/23/2003 | CN1412188A Production method of chlorophyll metal compound |
| 04/23/2003 | CN1106400C Antitumor indolophprolocarbazole derivatives |
| 04/23/2003 | CN1106399C Process for preparing sildenafil |
| 04/23/2003 | CN1106395C Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 04/23/2003 | CN1106383C Estrogenic agents |
| 04/22/2003 | US6552196 Quinolone carboxylic acid derivatives |
| 04/22/2003 | US6552194 Process for the preparation of pure triethylenediamine (TEDA) |
| 04/22/2003 | US6552193 Chloropyrimidine intermediates |
| 04/22/2003 | US6552192 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 04/22/2003 | US6552187 Cyclization condensation of arylmalonic acid diamides or arylmalonic acid monoamides with hydrazine derivatives forming substituted 3-hydroxy-4-aryl-5-oxopyrazolines; high yield and purity |
| 04/22/2003 | US6552052 Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors |
| 04/22/2003 | US6552042 Anticoagulants |
| 04/22/2003 | US6552026 6-phenyl-pyrazolopyrimidines |
| 04/22/2003 | US6552021 Antitumor agent |
| 04/22/2003 | US6552018 As antitumor agents |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | US6552015 Azabicycloalkane derivatives and therapeutic uses thereof |
| 04/22/2003 | US6552012 Heteroaryl diazabicycloalkanes, their preparation and use |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/17/2003 | WO2003031448A1 Reverse-turn mimetics and method relating thereto |
| 04/17/2003 | WO2003031447A2 Pyrimidine derivatives |
| 04/17/2003 | WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003030907A1 Reverse-turn mimetics and composition and methods relating thereto |
| 04/17/2003 | WO2002069968A8 New use |
| 04/17/2003 | WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073852 Anticancer agents |
| 04/17/2003 | US20030073719 Chiral salt resolution |
| 04/17/2003 | US20030073708 Compounds specific to adenosine A3 receptor and uses thereof |
| 04/17/2003 | US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents |
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/17/2003 | US20030073679 Novel metallotexaphyrin derivatives |
| 04/17/2003 | US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301515A1 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| 04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 04/16/2003 | EP1301513A2 PYRROLO 3,4-d]PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 04/16/2003 | EP1301512A2 Bicyclic hydantoin derivatives and combinatorial libraries thereof |
| 04/16/2003 | EP1301511A2 IMIDAZO 1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 04/16/2003 | EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 04/16/2003 | EP1102769B1 Tricyclic carboxamides |
| 04/16/2003 | EP0970176B1 Photochemical superoxide generators |
| 04/16/2003 | EP0970083B1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 04/16/2003 | EP0960184B1 Photobleaching compositions comprising mixed metallocyanines |
| 04/16/2003 | EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105720C Imidazopyridazines compound |
| 04/16/2003 | CN1105717C Substituted sulphonylamino (thio) carbony/compounds |
| 04/15/2003 | US6548664 Alkylation, hydrogenation, cyclization, condensation, deracemization |
| 04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/15/2003 | US6548510 Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence |
| 04/15/2003 | US6548509 3-aryl substituted pyrazolo[4,3-D]pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
| 04/15/2003 | US6548501 Composition and methods for stimulating gastrointestinal motility |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548045 Anticancer agents |